Once again you have got the facts wrong....
Phase I trial results are due in December which is by my calculations approximately 2 and half months away.
A historical analysis of the share price by any trained monkey makes it quite clear that the current share price has not factored in a positive Phase I trial - the valuation is simply cash backing plus the services business. Any uplifts in valuation have come from positive news in relation to securing long term contracts for the services business...
A positive Phase I result on NSL-043 makes the company's 50% interest at least worth $30 million in any licensing transaction.........With a current market cap of $10 million - the company isnt going backwards
research , page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)